Taken together, these data demonstrate the development of novel mouse models of B-ALL that recapitulate common genetic, biochemical, and pathologic features of human CRLF2-rearranged/JAK2 mutant B-ALLs. This evidence concerns the gene CRLF2 and precursor B-cell acute lymphoblastic leukemia.